A protective APOE gene variant is enriched in Super Agers—people over 80 who think like 50‑year‑olds—cutting Alzheimer’s risk ...

Since July 2023, three anti-amyloid medications have been FDA-approved for the treatment of Alzheimer’s disease with more in development. A potential and serious side effect of anti-amyloid ...

For confidential advice, call Alzheimer's Society's Dementia Support Line on 0333 150 3456 Alzheimer's Society's symptoms checker can help spot the signs of dementia A single gene could be responsible ...

Women are significantly more likely than men to develop Alzheimer's disease. Earlier age at menopause is associated with a greater risk for late-life cognitive decline and Alzheimer's disease. A new ...

NEW YORK (Reuters Health) - Elderly patients who carry the apolipoprotein E (APOE) e4 allele, a gene mutation implicated in Alzheimer's disease, are at increased risk for experiencing early delirium ...

Role of the APOE gene has "long been underestimated" NINETY per cent of Alzheimer’s cases are linked to the same gene, scientists have discovered. About 750,000 people in the UK have the disease and ...

Revvity, Inc., announced today the launch of the in-vitro diagnostic EURORealTime ™ APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene.

People often worry they will get Alzheimer’s disease if their parents did. But engaging in a healthy lifestyle can outweigh ...